We are live on ! Find out more
TC

Tejara Capital Portfolio holdings

AUM $243M
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+9.84%
3 Year Est. Return
+17.31%
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
-$24M
Cap. Flow
-$43.5M
Cap. Flow %
-22.67%
Top 10 Hldgs %
53.31%
Holding
77
New
7
Increased
17
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$3.86M
2
GLNG icon
Golar LNG
GLNG
+$2.48M
3
NOV icon
NOV
NOV
+$2.15M
4
EXE
Expand Energy Corp
EXE
+$2.05M
5
HUM icon
Humana
HUM
+$1.89M

Sector Composition

Rank Sector Weight
1 Energy 57.03%
2 Healthcare 34.47%
3 Miscellaneous 4.87%
4 Technology 3.1%
5 Industrials 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEC
1
Diversified Energy Company
DEC
$1.04B
$27.4M 14.27%
1,952,906
+47,573
+2% +$713K
CNR
2
Core Natural Resources Inc
CNR
$5.01B
$10.6M 5.51%
126,589
+312
+0.2% +$23.4K
ARQT icon
3
Arcutis Biotherapeutics
ARQT
$2.99B
$9.81M 5.12%
520,503
-352,878
-40% -$5.57M
NVDA icon
4
PUT
NVIDIA
NVDA
$5.25T
$9.33M 4.87%
+50,000
New +$8.72M
NOV icon
5
NOV
NOV
$7.48B
$8.88M 4.63%
670,199
+166,692
+33% +$2.15M
GLNG icon
6
Golar LNG
GLNG
$5.13B
$7.94M 4.14%
196,526
+60,093
+44% +$2.48M
NE icon
7
Noble Corp
NE
$7.31B
$7.81M 4.07%
276,148
-49,798
-15% -$1.41M
ROIV icon
8
Roivant Sciences
ROIV
$25.1B
$7.66M 3.99%
506,095
+43,082
+9% +$533K
MRVI icon
9
Maravai LifeSciences
MRVI
$1.14B
$7.04M 3.67%
2,453,441
+511,992
+26% +$1.31M
HRTX icon
10
Heron Therapeutics
HRTX
$62M
$5.78M 3.02%
4,589,715
+72,300
+2% +$115K
SDRL icon
11
Seadrill
SDRL
$2.98B
$5.54M 2.89%
183,252
-38,114
-17% -$1.16M
VAL icon
12
Valaris
VAL
$5.99B
$5.38M 2.81%
110,392
-10,974
-9% -$535K
SLB icon
13
SLB Ltd
SLB
$85.1B
$4.77M 2.49%
138,759
+111,059
+401% +$3.86M
FET icon
14
Forum Energy Technologies
FET
$907M
$4.25M 2.22%
158,989
-20,048
-11% -$463K
ESTA icon
15
Establishment Labs
ESTA
$2.11B
$4.2M 2.19%
102,494
+24,386
+31% +$996K
VTRS icon
16
Viatris
VTRS
$18.8B
$4.18M 2.18%
422,620
-30,873
-7% -$301K
BORR
17
Borr Drilling
BORR
$1.37B
$4.08M 2.13%
1,518,261
+548,441
+57% +$1.36M
REKR icon
18
Rekor Systems
REKR
$75.5M
$4M 2.09%
2,548,950
-354,515
-12% -$448K
MREO
19
Mereo BioPharma
MREO
$40.3M
$3.93M 2.05%
1,906,844
-523,593
-22% -$965K
CERT icon
20
Certara
CERT
$1.27B
$3.34M 1.74%
273,052
+132,927
+95% +$1.45M
HAL icon
21
Halliburton
HAL
$30.1B
$3.31M 1.72%
134,365
+66,765
+99% +$1.48M
QDEL icon
22
QuidelOrtho
QDEL
$1.01B
$3.11M 1.62%
105,627
+18,165
+21% +$497K
NXE icon
23
NexGen Energy
NXE
$6.97B
$3.09M 1.61%
345,425
-40,044
-10% -$295K
PTEN icon
24
Patterson-UTI
PTEN
$4.74B
$2.87M 1.5%
554,993
+218,856
+65% +$1.26M
CRDL
25
Cardiol Therapeutics
CRDL
$227M
$2.81M 1.47%
2,630,122
-635,697
-19% -$771K

Similar funds

Tejara Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Tejara Capital held 77 positions worth $192M, down 11% from $216M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Tejara Capital withdrew a net $43.5M in Q3 2025, closing 30 positions and reducing 23 holdings. Its most notable exit was National Energy Services Reunited Corp, an estimated $4.54M position sold in full.

By sector, the portfolio is most concentrated in Energy at 57% of assets, up from 49% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Tejara Capital opened a new position in Expand Energy Corp worth $2.17M.

  • Tejara Capital's largest Q3 2025 buy was Expand Energy Corp: 20,400 shares worth $2.17M.
  • Tejara Capital added most to SLB Ltd in Q3 2025, an estimated $3.86M increase.
  • Tejara Capital's biggest Q3 2025 reduction was Arcutis Biotherapeutics, cutting an estimated $5.57M.
  • Tejara Capital fully exited National Energy Services Reunited Corp in Q3 2025, selling an estimated $4.54M.
  • Tejara Capital's ten largest holdings make up 53% of its $192M portfolio in Q3 2025.
  • Tejara Capital opened 7 new positions and closed 30 in Q3 2025.
  • Tejara Capital's portfolio value fell 11% quarter-over-quarter to $192M.

Based on Tejara Capital's 13F filing for Q3 2025, filed 4 Nov 2025.